Recombinant Human VEGFR2/KDR protein (hFc Tag)
种属
Human
纯度
>95 %, SDS-PAGE
标签
hFc Tag
生物活性
EC50: 7-30 ng/mL
验证数据展示
产品信息
| 纯度 | >95 %, SDS-PAGE |
| 内毒素 | <0.1 EU/μg protein, LAL method |
| 生物活性 |
Immobilized Human VEGF165 (His tag) at 0.1 μg/mL (100 μL/well) can bind Human VEGFR2 (hFc tag) with a linear range of 7-30 ng/mL. |
| 来源 | HEK293-derived Human VEGFR2 protein Ala20-Glu764 (Accession# P35968-1) with a human IgG1 Fc tag at the C-terminus. |
| 基因ID | 3791 |
| 蛋白编号 | P35968-1 |
| 预测分子量 | 110.3 kDa |
| SDS-PAGE | 125-150 kDa, reducing (R) conditions |
| 组分 | Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
| 复溶 | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
| 储存条件 |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
| 运输条件 | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
背景信息
VEGFR2, also named as KDR, FLK1 and CD309, is one of the two tyrosine kinase receptors involved in angiogenesis. VEGFR2 is mainly distributed in vascular endothelial cells, lymphatic endothelial cells, and embryonic precursor cells, and can bind to VEGF-A, VEGF-C, and VEGF-D. When activated by its ligand VEGF, VEGFR2 promotes neighbouring vessel formation to facilitate the delivery of growth factors, nutrients and oxygen for cancer proliferation, migration, metastasis and survival. VEGF and VEGFR2 mediated angiogenesis contributes to the aggressive natures and leads to high mortality rate in gastric cancer.
参考文献:
1. Xinrong Wang. et al. (2020). Front Cell Dev Biol. 8:599281 2. Michael Simons. et al. (2016). Nat Rev Mol Cell Biol. 17(10):611-25. 3. Jing Yu. et al. (2016). J Hematol Oncol. 9(1):111. 4. Seong Ah Park.et al. (2018). BMB Rep. 51(2):73-78.

